Hematology – Leading the Way

When I was elected to be President of SOHO, I was promised by Dr. Kantarjian that it was going to be a relatively light-workload experience. However, one of the requirements for the President is to develop an extended summary of hematologic malignancies, where we have been, where we are, and where we are going. In this era when the technology has expanded at a rapid rate leading to development of new agents mainly by the pharmaceutical industry, the complexity of writing such a summary has been complicated to say the least.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research